Platelet Function Testing and Genotyping for Tailoring Treatment in Complex PCI Patients.

US Cardiol · 2021 · PMC11664785 · PMID 39720484

Europe PMC DOI

hedged sentence

0.0560

closest p · 1.1× alpha

0.0560

boldest claim

The sentences

marginally non-significantp=0.056so close (0.05 < p ≤ 0.1)

with routine care (clopidogrel 75 mg as directed) in patients undergoing PCI (electively or for ACS).[ 34 – 38 ] The reduction of MACE (non-fatal MI or stroke, cardiovascular death, severe recurrent ischemia or stent thrombosis) at 1 year in the genotyping compared with the non-genotyping group was marginally non-significant (4% versus 5.9%; HR 0.66; p=0.056).

also in 338 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.